LTR Pharma Limited (ASX:LTP)
0.3950
+0.0100 (2.60%)
At close: May 2, 2025, 4:00 PM AEST
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 70.58 million as of May 2, 2025. Its market cap has increased by 77.63% in one year.
Market Cap
70.58M
Enterprise Value
36.51M
Revenue
499.71K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 70.58M, an increase of 33.22%. That is a compound annual growth rate of 22.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 2, 2025 | 70.58M | -51.85% |
Dec 31, 2024 | 146.59M | 204.77% |
Dec 29, 2023 | 48.10M | -9.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 124.16B |
Pro Medicus | 24.92B |
Cochlear | 18.02B |
Sonic Healthcare | 12.51B |
Telix Pharmaceuticals | 9.91B |
Ramsay Health Care | 7.88B |
Ansell | 4.47B |
Mesoblast | 2.36B |